Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 90.30
-3.60 (-3.83%)
At close: Mar 12, 2026
Cosmo Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.61 | 133.24 | -10.78 | 17.23 | 21.67 |
Depreciation & Amortization | 12.76 | 12.29 | 11.85 | 13.86 | 7.37 |
Loss (Gain) From Sale of Assets | 0.03 | - | - | - | - |
Asset Writedown & Restructuring Costs | 0.14 | 0.62 | 0.13 | 0 | - |
Loss (Gain) From Sale of Investments | -4.02 | -2.35 | -0.95 | -0.09 | 0.68 |
Loss (Gain) on Equity Investments | - | - | - | - | -17.75 |
Stock-Based Compensation | 2.6 | 2.07 | 3.83 | 2.08 | 1.46 |
Provision & Write-off of Bad Debts | 0.18 | 2.43 | 1.02 | - | - |
Other Operating Activities | -16.08 | 14 | 16.66 | 13.47 | 3.89 |
Change in Accounts Receivable | -5.38 | 9.24 | 5.19 | -14.16 | 3.29 |
Change in Inventory | 3.08 | 0.69 | -2.7 | 1.62 | -6.07 |
Change in Accounts Payable | 0.76 | -0.01 | 0.9 | -0.93 | 0.47 |
Change in Unearned Revenue | - | - | 1.4 | 0.51 | -0.94 |
Change in Income Taxes | -2.05 | -3.2 | -3.55 | -2.74 | -1.36 |
Change in Other Net Operating Assets | -0.88 | -6.59 | -0.3 | 2.39 | -0.46 |
Operating Cash Flow | -12.48 | 162.41 | 22.71 | 33.23 | 12.61 |
Operating Cash Flow Growth | - | 615.22% | -31.66% | 163.47% | -2.88% |
Capital Expenditures | -4.21 | -4.55 | -3.35 | -4.52 | -5.49 |
Cash Acquisitions | - | - | - | - | 23.34 |
Sale (Purchase) of Intangibles | -1.26 | -1.1 | -1.05 | -2.79 | -2.99 |
Investment in Securities | 54.99 | -123.45 | 56.78 | -18.13 | 6.74 |
Other Investing Activities | 0.94 | 0.23 | 0.83 | 2.13 | 3.06 |
Investing Cash Flow | 50.47 | -128.88 | 53.22 | 1.69 | 24.86 |
Long-Term Debt Repaid | -1.14 | -1.08 | -176.03 | -0.92 | -2.62 |
Net Debt Issued (Repaid) | -1.14 | -1.08 | -176.03 | -0.92 | -2.62 |
Issuance of Common Stock | 21.78 | 3.38 | 0.69 | 0.27 | 0.76 |
Repurchase of Common Stock | -7.92 | -5.93 | -12.48 | -24.75 | -20.51 |
Common Dividends Paid | -32.68 | -32.09 | -16.89 | -15.61 | - |
Other Financing Activities | -4.5 | -4.5 | -6.56 | -5.13 | -4.88 |
Financing Cash Flow | -24.45 | -40.22 | -211.27 | -46.13 | -27.25 |
Foreign Exchange Rate Adjustments | -1.96 | 0.72 | -0.21 | -1.52 | 2.4 |
Net Cash Flow | 11.57 | -5.98 | -135.55 | -12.74 | 12.62 |
Free Cash Flow | -16.69 | 157.86 | 19.36 | 28.71 | 7.12 |
Free Cash Flow Growth | - | 715.35% | -32.56% | 303.00% | -19.64% |
Free Cash Flow Margin | -16.02% | 59.17% | 20.87% | 28.12% | 10.95% |
Free Cash Flow Per Share | -1.04 | 9.62 | 1.20 | 1.75 | 0.42 |
Cash Interest Paid | - | - | 4.38 | 4.38 | 4.38 |
Cash Income Tax Paid | 20.16 | 7.47 | 3.98 | 1.96 | 2.63 |
Levered Free Cash Flow | -18.38 | 117.24 | 19.07 | 11.7 | -10.47 |
Unlevered Free Cash Flow | -18.31 | 117.27 | 24.4 | 17.43 | -4.85 |
Change in Working Capital | -4.47 | 0.11 | 0.95 | -13.31 | -5.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.